Incidences of Serious Infections and Tuberculosis among Patients Receiving Anti-Tumor Necrosis Factor-α Therapy

PURPOSE: Anti-tumor necrosis factor-alpha (TNF-α) medications represent a major advancement in the management of chronic inflammatory diseases. However, these agents are associated with increased risks of tuberculosis (TB) and other serious infections. The aim of this study was to evaluate the incid...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoo, In Kyung, Choung, Rok Seon, Hyun, Jong Jin, Kim, Seung Young, Jung, Sung Woo, Koo, Ja Seol, Lee, Sang Woo, Choi, Jai Hyun, Kim, Ho, Lee, Hong Sik, Keum, Bora, Kim, Eun Sun, Jeen, Yoon Tae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3936648/
https://www.ncbi.nlm.nih.gov/pubmed/24532516
http://dx.doi.org/10.3349/ymj.2014.55.2.442

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3936648/
https://www.ncbi.nlm.nih.gov/pubmed/24532516
http://dx.doi.org/10.3349/ymj.2014.55.2.442

Ejemplares similares